Product Information
ROSYRAH TABLET is a generic product labeled by Xiromed LLC, priced at $1.4379 per EA under NDC 70700031287. Its NADAC has been published 30 times since Jul 9, 2025.
FDA first approved this application on Oct 2, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Xiromed LLCNDC
70700031287
Classification
Generic
Dosage Form
KIT
Route
ORAL
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA206053FDA Approved
10/2/2017
TE Code
AB
On Market Since
1/29/2025
Price Statistics
The NADAC for ROSYRAH TABLET has been published 30 times since Jul 9, 2025, and over the history we have for it it has risen 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4379 per EA |
|---|---|
| All-time high | $1.7000 (Jun 10, 2026) |
| All-time low | $1.2238 (Jul 9, 2025) |
| 52-week high | $1.7000 |
| 52-week low | $1.2803 |
| Median price | $1.2850 |
| Average price | $1.4275 |
| Largest weekly change | +32.8% (May 20, 2026) |
| Weeks tracked | 30 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROSYRAH TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROSYRAH TABLET, manufactured by Xiromed LLC, is $1.4379 per EA (NDC 70700031287), effective Aug 19, 2026.
How has the price of ROSYRAH TABLET changed over time?
Over the history we have for it, the NADAC for ROSYRAH TABLET has risen 17.5%. It has been tracked across 30 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for ROSYRAH TABLET?
Since Jul 9, 2025, the NADAC for ROSYRAH TABLET has ranged from a low of $1.2238 (Jul 9, 2025) to a high of $1.7000 (Jun 10, 2026), with a median of $1.2850 per EA.
Are there cheaper alternatives to ROSYRAH TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ROSYRAH TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROSYRAH TABLET?
ROSYRAH TABLET (NDC 70700031287) is labeled by Xiromed LLC, and CMS classifies it as a generic product.